Cargando…
In vivo evaluation of nanostructured lipid carrier systems (NLCs) in mice bearing prostate cancer tumours
Nanostructure lipid carriers (NLCs) were developed for the delivery of curmumin (CRN), a potent anticancer agent with low bioavailability, for the treatment of prostate cancer. NLCs prepared using high pressure homogenization (HPH) with around 150 nm particle size, − 40 V ζ-potential and excellent l...
Autores principales: | Akanda, Mushfiq, Getti, Giulia, Douroumis, Dennis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315352/ https://www.ncbi.nlm.nih.gov/pubmed/34845679 http://dx.doi.org/10.1007/s13346-021-01095-1 |
Ejemplares similares
-
Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies
por: Elmowafy, Mohammed, et al.
Publicado: (2021) -
Atorvastatin-loaded nanostructured lipid carriers (NLCs): strategy to overcome oral delivery drawbacks
por: Elmowafy, Mohammed, et al.
Publicado: (2017) -
Formulation And Evaluation Of Nanostructured Lipid Carriers (NLCs) Of 20(S)-Protopanaxadiol (PPD) By Box-Behnken Design
por: Kim, Min-Hwan, et al.
Publicado: (2019) -
SN38 loaded nanostructured lipid carriers (NLCs); preparation and in vitro evaluations against glioblastoma
por: Shirazi, Ali Sabouri, et al.
Publicado: (2021) -
Drug Delivery of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) to Target Brain Tumors
por: Mehrdadi, Soheil
Publicado: (2023)